The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV–HCV Coinfection

The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV–HCV Coinfection

(1) Background: Direct-acting antiviral therapy for chronic hepatitis C virus (HCV) infection is associated with high sustained virologic response (SVR) and overcomes negative predictive factors, including steatosis, in patients without human immunodeficiency virus (HIV) coinfection. The impact of s...

Full description

Bibliographic Details
Main Authors: Leigh P. Johnson, Richard K. Sterling
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Biology
Subjects:
hepatic steatosis
sustained virologic response (SVR)
direct-acting antiviral (DAA) therapy
hepatitis C virus (HCV)
human immunodeficiency virus (HIV)
Online Access:https://www.mdpi.com/2079-7737/9/4/87

Internet

https://www.mdpi.com/2079-7737/9/4/87

Similar Items